Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Estimation of Excess Mortality in Germany During 2020-2022
Christof Kuhbandner, Matthias Reitzner
Cureus (2023)
Open Access | Times Cited: 11

Showing 11 citing articles:

Excess mortality across countries in the Western World since the COVID-19 pandemic: ‘Our World in Data’ estimates of January 2020 to December 2022
Saskia Mostert, Marcel Hoogland, Minke H. W. Huibers, et al.
BMJ Public Health (2024) Vol. 2, Iss. 1, pp. e000282-e000282
Closed Access | Times Cited: 17
A comprehensive analysis of all-cause and cause-specific excess deaths in 30 countries during 2020
Gianfranco Alicandro, Carlo La Vecchia, Nazrul Islam, et al.
European Journal of Epidemiology (2023) Vol. 38, Iss. 11, pp. 1153-1164
Open Access | Times Cited: 32
SARS-CoV-2: A Glance at the Innate Immune Response Elicited by Infection and Vaccination
Nicola Manfrini, Samuele Notarbartolo, Renata Grifantini, et al.
Antibodies (2024) Vol. 13, Iss. 1, pp. 13-13
Open Access | Times Cited: 4
Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan
Miki Gibo, Seiji Kojima, Akinori Fujisawa, et al.
Cureus (2024)
Open Access | Times Cited: 4
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2
M. Nathaniel Mead, Stephanie Seneff, Jessica Rose, et al.
International Journal of Vaccine Theory Practice and Research (2024) Vol. 3, Iss. 2, pp. 1275-1344
Open Access | Times Cited: 2
Effects of the COVID-19 pandemic on life expectancy and premature mortality in the German federal states in 2020 and 2021
Isabella Marinetti, Dmitri A. Jdanov, Pavel Grigoriev, et al.
PLoS ONE (2023) Vol. 18, Iss. 12, pp. e0295763-e0295763
Open Access | Times Cited: 5
Reports of deaths are an exaggeration: all-cause and NAA-test-conditional mortality in Germany during the SARS-CoV-2 era
Robert Rockenfeller, Michael Günther, Falk Mörl
Royal Society Open Science (2023) Vol. 10, Iss. 8
Open Access | Times Cited: 3
A Case Report of Acute Lymphoblastic Leukaemia (ALL)/Lymphoblastic Lymphoma (LBL) Following the Second Dose of Comirnaty®: An Analysis of the Potential Pathogenic Mechanism Based on of the Existing Literature
Patrizia Gentilini, Janci C. Lindsay, Nafuko Konishi, et al.
(2024)
Open Access
A Case Report of Acute Lymphoblastic Leukaemia (ALL)/Lymphoblastic Lymphoma (LBL) Following the Second Dose of Comirnaty®: An Analysis of the Potential Pathogenic Mechanism Based on of the Existing Literature
Patrizia Gentilini, Janci C. Lindsay, Nafuko Konishi, et al.
(2024)
Open Access
Die Folgen der Pandemie
Lukas Radbruch
Der Schmerz (2024) Vol. 38, Iss. 3, pp. 173-174
Open Access
Longevity trend in Germany
Matthias Reitzner
European Actuarial Journal (2023) Vol. 14, Iss. 2, pp. 685-696
Open Access | Times Cited: 1
Page 1

Scroll to top